The aac(6')-Ik gene which confers resistance to aminoglycosides in Acinetobacter sp. 6 CIP A165 was characterized. The resistance gene was identified as a coding sequence of 438 bases pairs corresponding to a protein with a calculated mass of 16627 Da. Alignment of aac(6')-Ik with aac(6')-Ig from Acinetobacter haemolyticus indicated 83% identity. Like aac(6')-Ig of A. haemolyticus and aac(6')-lj of Acinetobacter sp. 13, the aac(6')-Ik gene was apparently located in the chromosome and was species specific. The high degree of identity between aac(6')-Ig and -Ik, compared with genomic DNA relationships between the host species, indicated that these genes have diverged from a common ancestor in a parental Acinetobacter species.
Introduction
Aminoglycosides are widely used in the treatment of severe Gram-negative infections, in part for their bactericidal effect. Moreover, a synergy is often observed when these aminoglycosides are combined with/3-1actams or fluoroquinolones [1] . However, massive aminoglycoside usage led to increased bacterial resistance. The most common resistance mechanism is enzymic modification of the drug [2] . Three activities are responsible for modification: acetylation, nucleotidylation and * Corresponding author. Tel.: (+33-1) 45 68 83 21; Fax:
(+33-1) 45 68 83 19 phosphorylation. Aminoglycoside-N-acetyltransferases (AAC) are divided into four classes, AAC(1), AAC(2'), AAC(3) and AAC(6'), designated according to the site of modification on the 2-deoxystreptamine core [3] . AAC(6') are of particular importance since they modify the aminoglycosides most used in therapy such as amikacin, gentamicin, netilmicin, sisomicin and tobramycin. Two types of AAC(6') can be distinguished on the basis of their substrate specificity: type I [AAC(6')-I] confers resistance to amikacin but not to gentamicin, whereas type II [AAC(6')-II] acetylates gentamicin but not amikacin. Ten genes, designated aac(6')-Ia to aac (6' )-Ij, encoding AAC(6')-I enzymes [3] [4] [5] [6] baumannii [6] . During the course of a study of intrinsic resistance to aminoglycosides in Acinetobacter spp. we found AAC(6') activity in Acinetobacter sp. 6 but total DNA of the strains did not hybridize with the probes specific for the aac(6')-I genes. We report here on the characterization of the aac(6')-Ik gene specific for Acinetobacter sp. 6.
Materials and Methods
Bacterial strains, plasmids and growth conditions Acinetobacter sp. 6 CIP A165 isolated from a throat sample was obtained from the collection of the Unit6 des Ent6robactdries at the Institut Pasteur in Paris, France. Acinetobacter sp. 6 Ac 222
OKI 24697 was also studied [7] . from our laboratory collection. Bacteria were grown in brain heart infusion broth (Difco) or on Mueller-Hinton (MH) agar (Sanofi Diagnostics Pasteur) at 37°C. MH medium supplemented with 5-bromo-4-chloro-3-indolyl-/3-x)-galactopyranoside (20 /zg m1-1) and isopropylthio-fl-D-galactopyranoside (40 /xg m1-1) was used to detect /3-galactosidase production. Antibiotic susceptibility testing was performed by disk-diffusion on MH agar. The method of Steers et al. [8] , with 104 cfu per spot, was used to determine the minimal inhibitory concentrations (MICs) of antibiotics on solid medium. Antibiotic concentrations for selection were: ampicillin, 100/xg ml-1 and tobramycin, 5/xg ml -a.
DNA manipulation
Total DNA [9] and small [10] and large scale [11] preparation of plasmid DNA was as described. Restriction enzyme-generated DNA fragments were separated in 0.8 and 1% agarose gels with a Tris-Borate-EDTA buffer system. The fragments were extracted by use of a QIAEX kit (Qiagen). For dot blot hybridization, DNA was immobilized on Nytran membrane filters (Schleicher & Schuell). Prehybridization and hybridization were as described [11] . The 188-bp HindlII-AvaI and 224-bp SspI-XbaI fragments internal to the aac(6')-Ig and aac(6')-Ik genes, respectively, were purified by electrophoresis in low-temperature-gelling agarose type VII (Sigma Chemical Co.), extracted [11] and radiolabelled by nick-translation [11] .
Assay for aminoglycoside-modifying enzymes
The activities of the aminoglycoside-modifying enzymes in bacterial extracts were detected by the phosphocellulose paper-binding technique [121.
Genetic techniques
Conjugation [11] into Escherichia coli K802N [13] , A. baumannii BM2582 [6] , transformation of E. coli HB101 and JM83 [11] , and curing of antibiotic-resistance traits with ethidium bromide [14] were performed as described.
DNA sequencing
Fragments of the aac(6')-lk gene and of its flanking regions were cloned into pUC19 [15] . DNA sequencing was performed by using universal primers (New England Biolabs) and synthetic oligodeoxynucleotides synthesized by the methoxy phosphoramidite method (Unit6 de Chimie Organique, Institut Pasteur). DNA sequencing was determined by the dideoxynucleotide chain termination method [16] with a modified T7 DNA polymerase and [a-35S]dATP. DNA fragments were resolved by electrophoresis in 6% polyacrylamide gels containing 7 M urea.
Computer analysis of sequence data
Nucleotide and amino acid sequences were analysed and compared by using GenBank, EMBL, and Swiss-Prot data bases with Genetics Computer Group software [17] and the FASTA program [18] . strains suggests production of a 6'-N-modifying enzyme [3] .
Enzymes and chemicals

Identification of aminoglycoside-modifying enzyme in CIP A165
Extracts of CIP A165 were shown to contain aminoglycoside acetyltransferase activity but no phosphotransferase or nucleotidyltransferase activity. Amikacin, gentamicins Cla and C2, netilmicin, 2'-N-ethylnetilmicin and tobramycin were modified, whereas gentamicin C1 and 6'-Nethylnetilmicin were not. The substrate profile of this enzyme was consistent with the presence of an AAC(6')-I activity.
Cloning of the aac(6')-Ik gene from CIP A165
Total DNA from CIP A165 digested with PuulI and pUC19 DNA cleaved by SmaI were mixed, ligated and introduced by transformation into E.
coli JM83. Transformants selected on ampicillin and tobramycin were screened for their plasmid content by agarose gel electrophoresis. The smallest recombinant plasmid, pAT476, contained a 4.5-kb fragment that conferred tobramycin resistance to the host by synthesis of an AAC(6')-I. The 3.2-kb EcoRI-PstI fragment of pAT476 was cloned into pUC19 digested by EcoRI plus PstI, generating pAT477, which also conferred tobramycin resistance to E. coli JM83. The 3.2-kb insert contained three HindlII fragments of 0.7, 0.8 and 1.7 kb which cloned separately and did not confer tobramycin resistance to E. coli JM83. This suggests that the aac(6')-I gene or its regulatory regions possess at least a HindIII site.
Nucleotide sequence of the aac(6')-Ik gene and of adjacent regions
The nucleotide sequence of the l153-bp insert of pAT477 plasmid was determined on both strands (Fig. 1) . A search for stop codons in the three reading frames of each DNA strand identified an open reading frame (ORF) spanning 477 nucleotides between the TAG and TAA codons located at positions 324 and 804, respectively. The ATG start codon at position 369 was preceded at 7 bp by a ribosome binding site (RBS)-like sequence (GGTGG) complementary to 4 bases (underlined) of the 3'-OH terminal sequence of E. coli 16S rRNA (5'-GAUCA CCUCCUUA-3'). This sequence, optimally spaced, is identical to the RBS of the aac(6')-Ig gene of A. haemolyticus [4] . Potential -35 and -10 promoter sequences (TTGAAA) and (TTTG AT) were found at positions 246-251 and 269-274, respectively. Like in canonic promoters, they were separated by 17 nucleotides [19] . The 438-bp sequence which extended from the ATG codon at position 369 to the TAA codon at position 804 could code for a protein of 145 amino acids with a calculated molecular mass of 16 627 Da. Two 13-bp inverted repeat sequences, separated by 2 bp, were present at positions 289-316. This secondary structure may correspond to a transcriptional attenuator. Identical sequences were also found upstream from the aac(6')-Ig gene. The G + C content of the aac(6')-Ik gene (40.7%) was similar to that of Acinetobacter sp. 6 chromosome (42%) [7] , suggesting that this gene is indigenous to this species. Relatedness of aac(6')-Ig to -Ik (83% identity) and of genomic Table 1 Sequence identity among the deduced amino acid sequences of 6'-N-acetyltransferases a Sequence Percent identity to compared AAC(6')-Id AAC(6')-If AAC(6')-Ig AAC(6')-Ih AAC(6')-Ij AAC(6')-Ik a Identity between pairs of sequences was derived from the alignment in Fig. 2 .
DNA of the corresponding hosts [20] suggests that these genes have derived from an ancestor originating in a parental Acinetobacter. Interestingly, flanking regions of both genes also exhibited 83% identity.
Comparison of AAC(6')-Ik and AAC(6')-Ig proteins
The amino acid sequences of AAC(6')-Ik and AAC(6')-Ig proteins were compared (Fig. 1) (Fig. 2) .
Genetic location of the aac(6')-Ik gene in CIP A165
All attempts to isolate plasmid DNA from CIP A165 were unsuccessful. Assays to transfer aminoglycoside resistance by conjugation from CIP A165 to A. baurnannii BM2582 and E. coli Acinetobacter sp. 6 and A. haemolyticus are closely related species [20] that can be biochemically differentiated only by utilization of DL-4-aminobutyrate as a sole source of carbon and energy [7] . In fact, only DNA/DNA hybridization using the $1 nuclease method or 16S rRNA sequencing are reliable to distinguish between these species. However, these methods are tedious and cannot be used in routine. Polymerase chain reaction with sequence-specific primers or hybridization with aac(6')-Ik and -Ig probes appear a simple and fast diagnostic tool for specification of Acinetobacter sp. 6 and A. haemolyti-CUS.
